Optical spectrophotometric methods are used to detect both plasma-free hemoglobin and antifactor Xa level, so hyperbilirubinemia can interfere with the measurement of both the monitoring laboratory tests for extracorporeal membrane oxygenation (ECMO) due to similar absorbance wavelengths. We present a seven-year-old child with acute respiratory failure on venovenous ECMO who developed an acute increase in plasma-free hemoglobin and undetectable antifactor Xa level due to acute hyperbilirubinemia from hepatic dysfunction related to antifungal therapy.
MalinauskasRA. Plasma hemoglobin measurement techniques for the in vitro evaluation of blood damage caused by medical devices. Artif Organs. 1997;21(12):1255–1267.
2.
YamaguchiMKurokawaTIshiyamaK. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study. Ann Hematol. 2011;90(10):1209–1217.
3.
KazmierczakSCRobertsonAFCatrouPGBrileyKPKreamerBLGourleyGR. Direct spectrophotometric method for measurement of bilirubin in newborns: comparison with HPLC and an automated diazo method. Clin Chem. 2002;48(7):1096–1097.
4.
WongSSSchenkelOJ. Quantification of plasma hemoglobin in the presence of bilirubin with bilirubin oxidase. Ann Clin Lab Sci. 1995;25(3):247–251.
